Berenberg Bank Raises Hikma Pharmaceuticals (LON:HIK) Price Target to GBX 2,300

Hikma Pharmaceuticals (LON:HIK) had its price objective boosted by equities researchers at Berenberg Bank from GBX 1,800 to GBX 2,300 in a research note issued to investors on Wednesday,Digital Look reports. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 83.71% from the company’s previous close.

Several other analysts also recently weighed in on the company. Peel Hunt reiterated a “buy” rating and set a GBX 2,170 price target on shares of Hikma Pharmaceuticals in a research note on Friday, November 7th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 2,360 target price on shares of Hikma Pharmaceuticals in a report on Friday, November 7th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Hikma Pharmaceuticals from GBX 2,500 to GBX 2,400 and set a “buy” rating on the stock in a report on Friday, January 9th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Hikma Pharmaceuticals from GBX 2,500 to GBX 2,400 and set an “overweight” rating for the company in a research note on Friday, November 7th. Five analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of GBX 2,326.

Hikma Pharmaceuticals Stock Performance

Shares of HIK traded up GBX 5 during trading hours on Wednesday, reaching GBX 1,252. 5,503,024 shares of the company traded hands, compared to its average volume of 6,712,777. The company has a quick ratio of 1.27, a current ratio of 1.82 and a debt-to-equity ratio of 63.59. The business has a fifty day moving average price of GBX 1,543.45 and a 200-day moving average price of GBX 1,632.29. Hikma Pharmaceuticals has a 12-month low of GBX 1,233 and a 12-month high of GBX 2,184. The stock has a market capitalization of £2.77 billion, a P/E ratio of 7.50, a P/E/G ratio of 2.38 and a beta of 0.72.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 800+ (as of Feb 2025) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.